Intermedical Care and Lab Hospital Valuation
Is IMH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IMH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IMH-R (THB5.95) is trading above our estimate of fair value (THB4.84)
Significantly Below Fair Value: IMH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IMH-R?
Other financial metrics that can be useful for relative valuation.
What is IMH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿1.27b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.9x |
Enterprise Value/EBITDA | 28.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IMH-R's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.9x | ||
KDH Thonburi Medical Centre | 1.5x | n/a | ฿1.8b |
AHC Aikchol Hospital | 1.4x | n/a | ฿2.5b |
NEW Wattana Karnpaet | 1.8x | n/a | ฿882.5m |
RPH Ratchaphruek Hospital | 2.8x | n/a | ฿3.2b |
IMH-R Intermedical Care and Lab Hospital | 1.7x | 22.9% | ฿1.3b |
Price-To-Sales vs Peers: IMH-R is good value based on its Price-To-Sales Ratio (1.7x) compared to the peer average (1.9x).
Price to Earnings Ratio vs Industry
How does IMH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Sales vs Industry: IMH-R is good value based on its Price-To-Sales Ratio (1.7x) compared to the TH Healthcare industry average (2.3x).
Price to Sales Ratio vs Fair Ratio
What is IMH-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.7x |
Fair PS Ratio | 3.1x |
Price-To-Sales vs Fair Ratio: IMH-R is good value based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (3.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.